ID

17273

Beskrivning

Effect of Thiazolidinedione Treatment Vascular Risk Markers; ODM derived from: https://clinicaltrials.gov/show/NCT00571506

Länk

https://clinicaltrials.gov/show/NCT00571506

Nyckelord

Versioner (1)
  1. 2016-09-03 2016-09-03 -
Uppladdad den

3 september 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Diabetes Mellitus, Type 2 NCT00571506

Engelsk

Eligibility Diabetes Mellitus, Type 2 NCT00571506

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
men and women of all races
Beskrivning

Gender | Racial group All

Datatyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0034510
UMLS CUI [2,2]
C0444868
age 40-65 years
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis of type 2 diabetes
Beskrivning

Diabetes Mellitus, Non-Insulin-Dependent

Datatyp

boolean

Alias
UMLS CUI [1]
C0011860
hemoglobin a1c ≥ 7%
Beskrivning

Glycosylated hemoglobin A

Datatyp

boolean

Alias
UMLS CUI [1]
C0019018
eligible whether or not currently taking antihyperglycemic medications
Beskrivning

Hypoglycemic Agents

Datatyp

boolean

Alias
UMLS CUI [1]
C0020616
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of rosiglitazone or pioglitazone use in the previous 3 months
Beskrivning

rosiglitazone | pioglitazone

Datatyp

boolean

Alias
UMLS CUI [1]
C0289313
UMLS CUI [2]
C0071097
known diagnosis of peripheral vascular disease or cardiac failure
Beskrivning

Peripheral Vascular Diseases | Heart failure

Datatyp

boolean

Alias
UMLS CUI [1]
C0085096
UMLS CUI [2]
C0018801
recent history (within past 6 months) of ischemic stroke, myocardial infarction, percutaneous coronary intervention, or coronary artery bypass surgery
Beskrivning

Ischemic stroke | Myocardial Infarction | Percutaneous Coronary Intervention | Coronary Artery Bypass Surgery

Datatyp

boolean

Alias
UMLS CUI [1]
C0948008
UMLS CUI [2]
C0027051
UMLS CUI [3]
C1532338
UMLS CUI [4]
C0010055
active liver disease or elevated serum transaminases (alt >2.5x upper limit of normal)
Beskrivning

Liver disease | Transaminases increased | Alanine aminotransferase measurement

Datatyp

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0438717
UMLS CUI [3]
C0201836
current therapy with oral anticoagulants (warfarin, heparin, low molecular weight heparin), clopidogrel, or immunosuppressive agents
Beskrivning

oral anticoagulants | Warfarin | Heparin | Heparin, Low-Molecular-Weight | clopidogrel | Immunosuppressive Agents

Datatyp

boolean

Alias
UMLS CUI [1]
C0354604
UMLS CUI [2]
C0043031
UMLS CUI [3]
C0019134
UMLS CUI [4]
C0019139
UMLS CUI [5]
C0070166
UMLS CUI [6]
C0021081
pregnancy or breastfeeding
Beskrivning

Pregnancy | Breast Feeding

Datatyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
any other condition, in the opinion of the investigator, that renders the subject unable to complete the study, that interferes with optimal participation in the study, or that produces significant risk to the subject
Beskrivning

Condition Compliance behavior Unable | Condition Interferes with Study Subject Participation Status | Condition At risk Significant Study Subject

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C1321605
UMLS CUI [1,3]
C1299582
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C2348568
UMLS CUI [3,1]
C0348080
UMLS CUI [3,2]
C1444641
UMLS CUI [3,3]
C0750502
UMLS CUI [3,4]
C0681850
Tillbaka till toppen

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT00571506

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Racial group All
Item
men and women of all races
boolean
C0079399 (UMLS CUI [1])
C0034510 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
Age
Item
age 40-65 years
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent
Item
diagnosis of type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Glycosylated hemoglobin A
Item
hemoglobin a1c ≥ 7%
boolean
C0019018 (UMLS CUI [1])
Hypoglycemic Agents
Item
eligible whether or not currently taking antihyperglycemic medications
boolean
C0020616 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
rosiglitazone | pioglitazone
Item
history of rosiglitazone or pioglitazone use in the previous 3 months
boolean
C0289313 (UMLS CUI [1])
C0071097 (UMLS CUI [2])
Peripheral Vascular Diseases | Heart failure
Item
known diagnosis of peripheral vascular disease or cardiac failure
boolean
C0085096 (UMLS CUI [1])
C0018801 (UMLS CUI [2])
Ischemic stroke | Myocardial Infarction | Percutaneous Coronary Intervention | Coronary Artery Bypass Surgery
Item
recent history (within past 6 months) of ischemic stroke, myocardial infarction, percutaneous coronary intervention, or coronary artery bypass surgery
boolean
C0948008 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
C1532338 (UMLS CUI [3])
C0010055 (UMLS CUI [4])
Liver disease | Transaminases increased | Alanine aminotransferase measurement
Item
active liver disease or elevated serum transaminases (alt >2.5x upper limit of normal)
boolean
C0023895 (UMLS CUI [1])
C0438717 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
oral anticoagulants | Warfarin | Heparin | Heparin, Low-Molecular-Weight | clopidogrel | Immunosuppressive Agents
Item
current therapy with oral anticoagulants (warfarin, heparin, low molecular weight heparin), clopidogrel, or immunosuppressive agents
boolean
C0354604 (UMLS CUI [1])
C0043031 (UMLS CUI [2])
C0019134 (UMLS CUI [3])
C0019139 (UMLS CUI [4])
C0070166 (UMLS CUI [5])
C0021081 (UMLS CUI [6])
Pregnancy | Breast Feeding
Item
pregnancy or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Condition Compliance behavior Unable | Condition Interferes with Study Subject Participation Status | Condition At risk Significant Study Subject
Item
any other condition, in the opinion of the investigator, that renders the subject unable to complete the study, that interferes with optimal participation in the study, or that produces significant risk to the subject
boolean
C0348080 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])
C0348080 (UMLS CUI [3,1])
C1444641 (UMLS CUI [3,2])
C0750502 (UMLS CUI [3,3])
C0681850 (UMLS CUI [3,4])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial